Chemical Stability of Esters of Nicotinic Acid Intended for Pulmonary Administration by Liquid Ventilation

Overview

Journal Pharm Res

Specialties Pharmacology
Pharmacy

Date 2003 Jun 24

PMID 12817898

Citations 8

Authors

Cheng-Hsuan Hsu

Michael Jay

Paul M Bummer

Hans-Joachim Lehmler

Affiliations

Soon will be listed here.

Abstract

Purpose: It has been suggested that fluorocarbon liquid may be a unique vehicle for the delivery of drugs directly to the acutely injured lung. A prodrug approach was used as a means of enhancing the solubility of a model drug (nicotinic acid) in the fluorocarbon. The solubility, the chemical stability of the putative prodrugs, and the sensitivity to enzymatic hydrolysis was investigated.

Methods: The solubility of each nicotinic acid ester was determined in buffer as a function of pH and in perflubron. The octanol/buffer partition coefficient was determined at pH 7.4. The chemical stability of the putative prodrugs was determined as a function of pH, temperature, buffer content, and ionic strength. In addition, sensitivity of the esters to enzymatic degradation was evaluated.

Results: Compared with nicotinic acid, the solubility in perflubron of the esters was significantly enhanced. In aqueous buffers, the esters exhibited pseudo-first order degradation kinetics, with both acid and base catalyzed loss. Studies of the fluorobutyl ester indicate quantitative loss of the putative prodrug and release of the parent nicotinic acid. Porcine esterase accelerated the loss of fluorobutyl ester by a factor of over 200 compared with chemical hydrolysis at pH 7.4.

Conclusions: The properties of the fluorinated esters suggest that they may be suitable candidates for further testing as possible prodrugs of nicotinic acid based upon higher solubility in perflubron, rapid release of the parent drug after simple hydrolysis, and sensitivity to the presence of a model esterase enzyme.

Citing Articles

The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants.

Cao L, Li Y, Yang S, Li G, Zhou Q, Sun J Sci Transl Med. 2022; 14(661):eabm7621.

PMID: 35579533 PMC: 9161374. DOI: 10.1126/scitranslmed.abm7621.

Nanoapproaches to Modifying Epigenetics of Epithelial Mesenchymal Transition for Treatment of Pulmonary Fibrosis.

Skibba M, Drelich A, Poellmann M, Hong S, Brasier A Front Pharmacol. 2021; 11:607689.

PMID: 33384604 PMC: 7770469. DOI: 10.3389/fphar.2020.607689.

Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity.

Naguib Y, Lansakara-P D, Lashinger L, Rodriguez B, Valdes S, Niu M Neoplasia. 2016; 18(1):33-48.

PMID: 26806350 PMC: 5965255. DOI: 10.1016/j.neo.2015.11.012.

Fluorophilicity of Alkyl and Polyfluoroalkyl 1 Nicotinic Acid Ester Prodrugs.

Ojogun V, Knutson B, Vyas S, Lehmler H J Fluor Chem. 2010; 131(7):784-790.

PMID: 20567608 PMC: 2887708. DOI: 10.1016/j.jfluchem.2010.04.001.

Partitioning of homologous nicotinic acid ester prodrugs (nicotinates) into dipalmitoylphosphatidylcholine (DPPC) membrane bilayers.

Ojogun V, Vyas S, Lehmler H, Knutson B Colloids Surf B Biointerfaces. 2010; 78(1):75-84.

PMID: 20227859 PMC: 2873030. DOI: 10.1016/j.colsurfb.2010.02.015.

References

Krise J, Narisawa S, Stella V . A novel prodrug approach for tertiary amines. 2. Physicochemical and in vitro enzymatic evaluation of selected N-phosphonooxymethyl prodrugs. J Pharm Sci. 1999; 88(9):922-7. DOI: 10.1021/js9803813. View

Krafft M . Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. Adv Drug Deliv Rev. 2001; 47(2-3):209-28. DOI: 10.1016/s0169-409x(01)00107-7. View

Williams T, Jay M, Lehmler H, Clark M, Stalker D, Bummer P . Solubility enhancement of phenol and phenol derivatives in perfluorooctyl bromide. J Pharm Sci. 1999; 87(12):1585-9. DOI: 10.1021/js980156l. View

Dias C, Anand B, Mitra A . Effect of mono- and di-acylation on the ocular disposition of ganciclovir: physicochemical properties, ocular bioreversion, and antiviral activity of short chain ester prodrugs. J Pharm Sci. 2002; 91(3):660-8. DOI: 10.1002/jps.10072. View

Lehmler H, Bummer P . Mixing of partially fluorinated carboxylic acids with their hydrocarbon analogs at the air-water interface. J Colloid Interface Sci. 2005; 249(2):381-7. DOI: 10.1006/jcis.2002.8282. View

Shaffer T, Wolfson M, CLARK Jr L . Liquid ventilation. Pediatr Pulmonol. 1992; 14(2):102-9. DOI: 10.1002/ppul.1950140208. View

Cullen A, Cox C, Hipp S, Wolfson M, Shaffer T . Intra-tracheal delivery strategy of gentamicin with partial liquid ventilation. Respir Med. 1999; 93(11):770-8. DOI: 10.1016/s0954-6111(99)90261-5. View

Brown O, Heitkamp M, Song C . Niacin Reduces Paraquat Toxicity in Rats. Science. 1981; 212(4502):1510-2. DOI: 10.1126/science.7233236. View

Franz A, Rohlke W, Franke R, Ebsen M, Pohlandt F, Hummler H . Pulmonary administration of perfluorodecaline- gentamicin and perfluorodecaline- vancomycin emulsions. Am J Respir Crit Care Med. 2001; 164(9):1595-600. DOI: 10.1164/ajrccm.164.9.2104088. View

10.

Morishita S, Saito T, Hirai Y, Shoji M, Mishima Y, Kawakami M . Synthesis and hypolipidemic activity of 2-substituted isobutyric acid derivatives. J Med Chem. 1988; 31(6):1205-9. DOI: 10.1021/jm00401a022. View

11.

Powell M . Enhanced stability of codeine sulfate: effect of pH, buffer, and temperature on the degradation of codeine in aqueous solution. J Pharm Sci. 1986; 75(9):901-3. DOI: 10.1002/jps.2600750917. View

12.

Tammara V, Narurkar M, Crider A, Khan M . Synthesis and evaluation of morpholinoalkyl ester prodrugs of indomethacin and naproxen. Pharm Res. 1993; 10(8):1191-9. DOI: 10.1023/a:1018976520391. View

13.

Weng Larsen S, Engelbrecht Thomsen A, Rinvar E, Friis G, Larsen C . Effect of drug lipophilicity on in vitro release rate from oil vehicles using nicotinic acid esters as model prodrug derivatives. Int J Pharm. 2001; 216(1-2):83-93. DOI: 10.1016/s0378-5173(01)00568-3. View

14.

Shaffer T, Wolfson M . Liquid ventilation: an alternative ventilation strategy for management of neonatal respiratory distress. Eur J Pediatr. 1996; 155 Suppl 2:S30-4. DOI: 10.1007/BF01958078. View

15.

Smith D, Gambone L, Tarara T, Meays D, Dellamary L, Woods C . Liquid dose pulmonary instillation of gentamicin PulmoSpheres formulations: tissue distribution and pharmacokinetics in rabbits. Pharm Res. 2002; 18(11):1556-61. DOI: 10.1023/a:1013078330485. View

16.

Wolfson M, Carlsson C, Shaffer T . Halothane administration during liquid ventilation. Respir Med. 1997; 91(5):255-62. DOI: 10.1016/s0954-6111(97)90028-7. View

17.

Durrer A, Boss G, Testa B . Enzymic hydrolysis of nicotinate esters: comparison between plasma and liver catalysis. Xenobiotica. 1992; 22(3):273-82. DOI: 10.3109/00498259209046639. View

18.

Nagai A, Yasui S, Ozawa Y, Uno H, Konno K . Niacin attenuates acute lung injury induced by lipopolysaccharide in the hamster. Eur Respir J. 1994; 7(6):1125-30. View

19.

Wang Q, Giri S, Hyde D, Nakashima J, Javadi I . Niacin attenuates bleomycin-induced lung fibrosis in the hamster. J Biochem Toxicol. 1990; 5(1):13-22. DOI: 10.1002/jbt.2570050104. View

20.

Nakazawa K, Yokoyama K, Matsuzawa Y, Makita K, Amaha K . Pulmonary administration of prostacyclin (PGI2) during partial liquid ventilation in an oleic acid-induced lung injury: inhalation of aerosol or intratracheal instillation?. Intensive Care Med. 2001; 27(1):243-50. DOI: 10.1007/s001340000756. View